Of note, IL-13 also functions synergistically with TGF-β to promote fibrosis and IL-13/ TGF-β blockade was more effective than single TGF-β blockade in alleviating hepatic fibrosis in NAFLD mice [115]. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatotic liver disease.